Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Study of the effect and related mechanism of Tongmai Yangxin Pill on atherosclerosis in ApoE-/- mice
Hits 881  Download times 804  Received:March 26, 2021  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2021.06.22
Key Words   atherosclerosis;Tongmai Yangxin Pill;microarray;ApoE-/- mice
Author NameAffiliation
XIAO Yang The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China 
LIU Ying The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China 
XU Yajie The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China 
LI Guozheng The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300250, China 
GENG Tong Tianjin Zhongxin Pharmaceutical Group Co., Ltd., Tianjin 300457, China 
XU Jinpeng Tianjin Zhongxin Pharmaceutical Group Co., Ltd., Tianjin 300457, China 
WANG Yi Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China 
Abstract
    [Objective] To observe the effect of Tongmai Yangxin Pill treated the arterial plaque in ApoE-/- mice and to explore the mechanism.[Methods] The ApoE-/- mice were randomly divided into four groups,including model group,Tongmai Yangxin Pill 2.0 g/kg group,Tongmai Yangxin Pill 1.0 g/kg group,Tongmai Yangxin Pill 0.5 g/kg group. C57BL/6J mice were control group. ApoE-/- mice were fed with high fat diet to establish atherosclerosis model. One hour after the last administration,the levels of total cholesterol (TC) and triglycerides (TG) in serum were determined by biochemical method. Oil red O staining and HE staining were used to observe the plaque formation and the degree of arterial constriction. Affymetrix mouse genome was used to detect the gene spectrum of mouse artery tissue,and the differential gene analysis,cluster analysis and ingenuity canonical pathway analysis were carried out to explore the pharmacodynamic mechanism of Tongmai Yangxin Pill. RT-PCR and ELISA were used to verify the key proteins or genes.[Results] Compared with the control group,Tongmai Yangxin Pill could effectively improve the formation of large area plaque and significantly improve the narrow artery in the model group. The differential gene enrichment analysis showed that Tongmai Yangxin Pill could inhibit the formation of plaque by affecting PPAR α/RXR α,matrix metalloproteinase signaling pathway and platelet-derived growth factor signaling pathway. The expression of PPAR α gene was significantly up-regulated and the levels of p-NF-κB,TNF-α,IL-6 and IL-1 β were significantly decreased.[Conclusion] Tongmai Yangxin Pill can effectively inhibit the formation of arterial plaque,activate PPAR α and inhibit the expression of inflammatory factors,which is one of the exact ways of drug effect.

You are the 2319528 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.